Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
New leaders appointed for Mölnlycke Health Care
Gothenburg, Sweden. 3 November 2026. Mölnlycke® announces the appointment of Anders Andersson as Chief Executive Officer (CEO) of Mölnlycke Health Care and Fredrik Wallefors as President of Surgical, effective 1 January 2027.
“Anders Andersson and Fredrik Wallefors both have the experience and drive needed to successfully lead our business into the future, maintaining our commitment to patients, healthcare professionals and customers,” says Karl-Henrik Sundström, Chair of the Board of Directors at Mölnlycke.
Anders Andersson is currently Executive Vice President (EVP) Wound Care at Mölnlycke and brings to the role a deep understanding of the business and customer needs. “It is an honour to take on the leadership of Mölnlycke Health Care into its next phase of innovation and profitable growth. Together with colleagues across the organisation, we will build on our strong foundations in wound care and infection prevention, while continuing to innovate and adapt new technologies to meet evolving customer needs and raise standards of healthcare worldwide,” Anders says.
Fredrik Wallefors is currently EVP OR Solutions at Mölnlycke and has strong knowledge and experience of the surgical market. “Our intention is to bring together our Operating Room Solutions and Gloves businesses, combining their strong positions in key segments with a broad range of complementary solutions. I look forward to building on these strengths as we continue our journey of profitable growth and support our customers in improving efficiency, safety and outcomes in surgical settings,” Fredrik says.
Mölnlycke has communicated its intention to separate into two stand-alone companies. Until the intended separation is completed, the businesses will continue to operate as Mölnlycke Health Care. From 1 January 2027, Anders Andersson will assume the CEO responsibilities of Mölnlycke Health Care and Fredrik Wallefors will be President of Surgical. The intention is that Fredrik Wallefors will assume the position as CEO of Mölnlycke Surgical if and when the separation and relevant consultations with employee representatives are completed. Guillaume Joucla will continue to serve as interim CEO of Mölnlycke Health Care until the end of 2026.
The intention is for Mölnlycke Health Care and Mölnlycke Surgical to become two stand-alone portfolio companies under Patricia Industries’ ownership. The separation is expected to be completed during 2027, subject to customary approvals.
Note to editors
Fredrik Wallefors’ title in Swedish as of 1 January 2027 is “Affärsområdeschef.”
For more information, please contact:
Latest news
-
Mölnlycke Health Care announces new partnership with DEBRA International to help advance wound care for the EB community
Mölnlycke is partnering with DEBRA International, the world’s leading epidermolysis bullosa (EB) patient advocacy network, to deepen understanding of the needs of people living with EB and help advance wound care for the global EB community.
-
Mölnlycke and AROA partner to expand access to Endoform in the US
Mölnlycke Health Care has entered an exclusive agreement with AROATM to co-promote EndoformTM in the United States in post-acute settings, effective 16 October 2026.
-
Martin Ma joins Mölnlycke Zhende as General Manager
In this role, Martin will lead the joint venture's operations and growth strategy in China, with responsibility for commercial execution, organisational leadership, governance and delivery of growth ambitions in one of the world's largest wound care markets.
-
Mölnlycke launches MyFit™ by Biogel® to bring more inclusive sizing to surgical gloves
-
Mölnlycke joins ALPS as Gold Strategic Partner to advance limb preservation
Mölnlycke has joined the American Limb Preservation Society (ALPS) as an official Gold Strategic Partner, reinforcing a shared commitment to improving outcomes for patients at risk of amputation due to diabetic foot complications.
-
New consensus document highlights need to address post-operative blistering to improve patient outcomes
At Mölnlycke Health Care, we work alongside clinicians, researchers and healthcare experts to advance evidence-based care and help raise standards for post-operative care.
-
From pressure to potential: new report reveals opportunity to increase healthcare capacity
Gothenburg, Sweden. 21 September 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, today announces the launch of The Hidden Capacity Report, a new international report revealing significant opportunities to expand day surgery and help healthcare systems improve efficiency, increase surgical throughput and enhance patient outcomes.
-
Mölnlycke to separate its surgical solutions business into a standalone company
Gothenburg, Sweden. 16 September 2026. Mölnlycke®, a global leader in MedTech, announces its intention to separate its Operating Room Solutions (ORS) and Gloves businesses into a new standalone company (referred to here as “Mölnlycke Surgical”). The separation is intended to create conditions for both Mölnlycke and Mölnlycke Surgical to reach their full potential and drive value creation long-term.
-
Major Scottish Hospital Adopts Steriwave®
UK’s Largest Hip and Knee Replacement Centre Becomes First in Scotland to Adopt Steriwave® Nasal Photodisinfection.